Will BioNTech’s Bold Bet on Cancer Revolutionize Treatment by 2026?
BioNTech's revenue dropped from €3.82 billion in 2023 to €2.75 billion in 2024, with losses expanding to €700 million from a €9.4 billion profit in 2021. The company is shifting…
BioNTech's revenue dropped from €3.82 billion in 2023 to €2.75 billion in 2024, with losses expanding to €700 million from a €9.4 billion profit in 2021. The company is shifting…